Document:

EX-10.4

 Exhibit 10.4 

EXECUTION VERSION 

PARTIAL ASSIGNMENT, ASSUMPTION AND BIFURCATION AGREEMENT 

This PARTIAL ASSIGNMENT, ASSUMPTION AND BIFURCATION AGREEMENT (this “Agreement”) is made and entered into by and between Alkermes
Pharma Ireland Limited, a private limited company incorporated in Ireland (registered number 448848) whose registered address is Connaught House, 1 Burlington Road, Dublin 4, Ireland (“APIL”), Recro Gainesville LLC, a Massachusetts limited
liability company with an address of 1300 Gould Drive, Gainesville, GA 30504 (“Recro Gainesville”), as successor in interest to Recro Technology LLC (f/k/a DV Technology LLC) and a wholly-owned subsidiary of Recro Pharma, Inc., a
Pennsylvania corporation with an address of 490 Lapp Road, Malvern PA 19355 (“Recro Pharma”), and Baudax Bio, Inc., a Pennsylvania corporation, with an address of 490 Lapp Road, Malvern PA 19355 (“Baudax”). 

WHEREAS, APIL and Recro Gainesville (as successor in interest to Recro Technology LLC, who is f/k/a DV Technology LLC) are parties to that
certain Asset Transfer and License Agreement dated April 10, 2015, as amended on December 23, 2015 and December 20, 2018, pursuant to which Recro Gainesville exclusively licenses the Nanotechnology IP and certain Licensed Trademarks
for the Nanotechnology IP for the Meloxicam IV/IM and Meloxicam Parenteral Formulation from APIL (the “Asset Transfer and License Agreement”); 

WHEREAS, Recro Pharma and Baudax are parties to that certain Separation Agreement, dated as of the date hereof, pursuant to which Recro Pharma
will (i) assign, or cause its subsidiaries to assign, certain assets related to the Acute Care Business (as defined in the Separation Agreement) to Baudax (the “Separation”) and (ii) distribute all of the issued and outstanding
common stock of Baudax to Recro Pharma’s shareholders (the “Distribution,” and the effective time of the Distribution, the “Distribution Time”); 

WHEREAS, in order to effect the Separation, effective immediately prior to the Distribution Time (the “Effective Time”), Recro
Gainesville desires to assign, convey, transfer and set over to Baudax certain of Recro Gainesville’s rights, benefits, privileges, interests and obligations under the Asset Transfer and License Agreement and Baudax desires to accept such
assignment, conveyance, transfer and set over from Recro Gainesville and to assume certain of Recro Gainesville’s obligations under the Asset Transfer and License Agreement and to agree to satisfy, pay, perform and discharge, as and when due,
such obligations, in each case, on the terms set forth herein; 
 NOW, THEREFORE, in consideration of the mutual covenants and agreements
contained herein, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: 

1. Effectiveness. This Agreement shall be effective as of the Effective Time. In the event that the Separation does not occur for any
reason, this Agreement will be null and void with no further action required on the part of either party. 
 2. Bifurcation, Partial
Assignment and Assumption. Recro Gainesville hereby irrevocably assigns, conveys and transfers to Baudax all of Recro Gainesville’s rights, benefits, privileges, interests, burdens, obligations and liabilities under the Asset Transfer and
License 

 Agreement to the extent related to the Acute Care Business (whether occurring on, before or after the
Effective Time) including, but not limited to, the rights and obligations set forth in Exhibit A of this Agreement (the “Assigned Rights and Obligations”). Recro Gainesville shall remain responsible for all other rights and
obligations under the Asset Transfer and License Agreement that are not bifurcated, assigned to and/or assumed by Baudax hereunder. APIL agrees and acknowledges that Baudax’s Assigned Rights and Obligations under the Asset Transfer and License
Agreement shall not be affected or limited by a breach of the Asset Transfer and License Agreement by Recro Gainesville. 
 3. Third Party
Beneficiary. In connection with the partial bifurcation, assignment and assumption of the Asset Transfer and License Agreement pursuant to Section 2 above, the parties agree and acknowledge that Baudax Bio is a third party beneficiary of
the Asset Transfer and License Agreement, entitled to enforce the provisions of the Asset Transfer and License Agreement as they relate to Assigned Rights and Obligations. 

4. Mutual Acceptance. Baudax unconditionally accepts the assignment, conveyance and transfer of the Assigned Rights and Obligations and,
without limiting the foregoing, assumes and agrees to satisfy, pay, perform and discharge, as and when due, all of the Assumed Obligations (as defined in Exhibit A of this Agreement) whether occurring on, before or after the Effective Time. 

5. Consent and Acknowledgment. APIL hereby consents to the partial bifurcation of the Asset Transfer and License Agreement as it relates
to the Assigned Rights and Obligations and the assignment by Recro Gainesville to Baudax of such Assigned Rights and Obligations. APIL hereby agrees that this Agreement satisfies any notice, consent or other procedural requirements under the Asset
Transfer and License Agreement with respect to the assignment of the Assigned Rights and Obligations and acknowledges and agrees that, notwithstanding Section 2.4 of Exhibit D to the Asset Transfer and License Agreement, APIL shall have no
further right of recourse against Recro Gainesville under the Asset Transfer and License Agreement with respect to the Assigned Rights and Obligations for periods after the Effective Time. APIL agrees to treat the Asset Transfer and License
Agreement as partially bifurcated and assigned as set forth in Sections 2 and 3 hereof. Without limiting the generality of the foregoing, APIL shall communicate directly with Baudax as a third party beneficiary to the Asset Transfer and License
Agreement with respect to the Assigned Rights and Obligations. 
 6. Disclaimer and Release. With respect to all Assigned Rights and
Obligations under the Asset Transfer and License Agreement that are assigned to and assumed by Baudax hereunder, Recro Gainesville hereby, without any further action, disclaims and is released from the Assigned Rights and Obligations under the Asset
Transfer and License Agreement, and Baudax shall have the sole right and responsibility in connection therewith. Recro Gainesville’s rights and obligations under the Asset Transfer and License Agreement shall not be affected or limited by a
breach of the Asset Transfer and License Agreement by Baudax. 
 7. Further Actions. Each of the parties hereto agrees to execute,
acknowledge and deliver, or cause the execution, acknowledgement and delivery of, such further documents and instruments and to perform such other reasonable actions as may reasonably be requested by a party hereto in order to effect the purposes of
this Agreement. 

  
 Page 2 of 3 

 8. Assignment. This Agreement shall inure to the benefit of the parties hereto and
their respective successors and assigns. Baudax may assign all or a portion of its Assigned Rights and Obligations to any purchaser of that portion of its business to which the Asset Transfer and License Agreement relates with the prior written
consent of APIL, which will not be unreasonably withheld, conditioned or delayed. 
 9. Governing Law. This Agreement and the
respective rights, duties and obligations of the parties hereunder shall be governed and construed in accordance with the laws of the State of Delaware, without giving effect to the conflict of laws provisions of that or any other jurisdiction. 

10. Miscellaneous. This Agreement may not be modified except by an instrument in writing executed by the parties hereto. This Agreement
may be executed in one or more counterparts and by facsimile, each of which shall be deemed an original and all of which, taken together, shall constitute one and the same instrument. The waiver by either party of any default, breach, or right of
this Agreement shall not constitute a waiver of any other or subsequent default, breach, or right. Section and paragraph headings in this Agreement are included herein for convenience of reference only and shall not modify, define, expand or limit
any of the terms or provisions of this Agreement. Capitalized terms used herein and not otherwise defined shall have the respective meanings given to them in the Asset Transfer and License Agreement. 

[Signature Page Follows] 

  
 Page 3 of 3 

 IN WITNESS WHEREOF, the parties hereto have executed this Partial Assignment, Assumption and
Bifurcation Agreement to be effective as of the Effective Time. 
  

			
	ALKERMES PHARMA IRELAND
	LIMITED
		
	By:	 	 /s/ Richie Paul

	Name: Richie Paul
	Title: Director
	
	RECRO GAINESVILLE LLC
		
	By:	 	 /s/ Gerri Henwood

	Name: Gerri Henwood
	Title: President
	
	BAUDAX BIO, INC.
		
	By:	 	 /s/ Gerri Henwood

	Name: Gerri Henwood
	Title: President

 [Signature page to Partial Assignment, Assumption and Bifurcation Agreement] 

 EXHIBIT A 

ASSIGNED RIGHTS OBLIGATIONS 

Assigned Rights: The rights under the following sections of the Asset Transfer and License 

Agreement: Section 3(a), Section 3(e) solely as it relates to the NanoCrystal Licensed Trademark, Section 3(f) solely as it relates to the
Nanotechnology Patents, and Section 3(g) solely as it relates to the Nanotechnology Patents and Section 7. 
 Assumed Obligations: The
obligations under the following sections of the Asset Transfer and License Agreement: Section 3(a), Section 3(e) solely as it relates to the NanoCrystal Licensed Trademark, Section 3(f) solely as it relates to the Nanotechnology
Patents, Section 3(g) solely as it relates to the Nanotechnology Patents, and all obligations under Section 5 as it relates to Earn-Out Products and Exhibit D.Document

FIRST INCREMENTAL ASSUMPTION AGREEMENT
This FIRST Incremental Assumption Agreement, dated as of November 26, 2019 (this “Agreement”), is made by and among Credit Suisse AG, Cayman Islands Branch (the “2019 Incremental Lender”), Upland Software, Inc., as the Borrower (as defined below), the Guarantors (as defined below) identified on the signature pages hereof as such, and Credit Suisse AG, Cayman Islands Branch, as the agent (the “Agent”). 
RECITALS:
 WHEREAS, reference is hereby made to that certain Credit Agreement, dated as of August 6, 2019 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), made by and among Upland Software Inc., a Delaware corporation (“Borrower”), the subsidiaries of the Borrower party thereto from time to time as guarantors (the “Guarantors”), the several lenders from time to time parties thereto (each, a “Lender” and, collectively, the “Lenders”), and Credit Suisse AG, Cayman Islands Branch, as the Agent (capitalized terms used but not defined herein having the meaning provided in the Credit Agreement); 
WHEREAS, subject to the terms and conditions of the Credit Agreement, the Borrower may establish Incremental Commitments by, among other things, entering into one or more Incremental Assumption Agreements with Incremental Lenders; and
WHEREAS, the Borrower has notified the Agent that, pursuant to the provisions of Section 2.15 of the Credit Agreement, it is requesting the 2019 Incremental Commitment (as defined below), under which the Borrower intends to incur Incremental Term Loans in an aggregate principal amount of $190,000,000 (the “2019 Incremental Term Loans”) pursuant to the terms of this Agreement; 
NOW, THEREFORE, in consideration of the premises and agreements, provisions and covenants herein contained, the parties hereto hereby agree as follows:
The 2019 Incremental Lender party hereto hereby agrees to make, on the 2019 Incremental Term Loan Borrowing Date (as defined below), Incremental Term Loans in an amount equal to its Incremental Term Loan Commitment (the “2019 Incremental Commitment”), as set forth on Schedule A annexed hereto, on the terms and subject to the conditions set forth below.
The 2019 Incremental Lender hereby (i) confirms that it has received a copy of the Credit Agreement and the other Loan Documents and the schedules and exhibits attached thereto, together with copies of the financial statements referred to therein and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this Agreement; (ii) agrees that it will, independently and without reliance upon the Agent, any other Incremental Lender or any other Lender and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Credit Agreement; (iii) appoints and authorizes the Agent to take such action as agent on its behalf and to exercise such powers under the Credit Agreement and the other Loan Documents as are delegated to the Agent, as the case may be, by the terms thereof, together with such powers as are reasonably incidental thereto; and (iv) agrees that it will perform in accordance with their terms all of the obligations which by the terms of the Credit Agreement are required to be performed by it as an Incremental Lender.
The 2019 Incremental Lender hereby agrees to make available its 2019 Incremental Commitment on the following terms and conditions: 

1.2019 Incremental Term Loans:  Upon the funding of the 2019 Incremental Term Loans (such date, the “2019 Term Loan Increase Effective Date”), the 2019 Incremental Term Loans shall constitute an increase to and a part of the “Initial Term Loans”, shall be designated as part of the same Class of Term Loans as the Initial Term Loans, and the 2019 Incremental Lender (and each of its successors and permitted assigns with respect to the 2019 Incremental Term Loans) will be a “Term Loan Lender”, as each is defined in the Credit Agreement.  After the execution of this Agreement by the parties hereto, each reference in the Credit Agreement to “Initial Term Loans”, and each reference in the Credit Agreement to “Term Loan Lender” shall include, respectively, the 2019 Incremental Term Loans and the 2019 Incremental Lender (and each of its successors and permitted assigns with respect to the 2019 Incremental Term Loans).  The Agent shall take any and all action as may be reasonably necessary to ensure that the 2019 Incremental Term Loans are included in each repayment of Initial Term Loans on a pro rata basis.  In furtherance of the foregoing, on the 2019 Term Loan Increase Effective Date, there shall commence an initial Interest Period with respect to the 2019 Incremental Term Loans, which Interest Period shall end on the last day of the Interest Period then-applicable to the Initial Term Loans outstanding immediately prior to the 2019 Term Loan Increase Effective Date. Amounts borrowed in accordance with this Incremental Assumption Agreement and repaid or prepaid may not be re-borrowed. 2019 Incremental Term Loans may be Base Rate Loans or Eurodollar Loans.
2.Applicable Margin.  The Applicable Margin for Base Rate Loans or for Eurodollar Loans, as applicable, for each 2019 Incremental Term Loan shall mean, as of any date of determination, the applicable percentage per annum as set forth in the Credit Agreement for the Initial Term Loans.
3.Principal Payments.  The principal amount of the 2019 Incremental Term Loans shall be repaid, together with the rest of the Initial Term Loan, in Dollars, for the ratable benefit of the Lenders then holding the 2019 Incremental Term Loans, on the last Business Day of each December, March, June and September, commencing December 31, 2019, in a principal amount equal to 0.25% of the aggregate principal amount of all 2019 Incremental Term Loan made on (and as of) the 2019 Term Loan Increase Effective Date, which payments shall be made in accordance with Section 2.2 of the Credit Agreement, and reduced as a result of prepayments of the 2019 Incremental Term Loans in accordance with Section 2.4 of the Credit Agreement.
4.Prepayment Premium.  In the event that, on or prior to the six-month anniversary of the 2019 Term Loan Increase Effective Date, the Borrower (i) makes any prepayment of 2019 Incremental Term Loans and/or Initial Term Loans in connection with any Repricing Transaction or (ii) effects any amendment of this Agreement resulting in a Repricing Transaction, the Borrower shall pay to the Agent, for the ratable account of each of the Term Loan Lenders holding Initial Term Loans and 2019 Incremental Term Loans, (x) in the case of clause (i), a prepayment premium of 1.00% of the principal amount of such 2019 Incremental Term Loans and Initial Term Loans being prepaid in connection with such Repricing Transaction and (y) in the case of clause (ii), an amount equal to 1.00% of the aggregate amount of the applicable 2019 Incremental Term Loans and Initial Term Loans outstanding immediately prior to such amendment that are subject to an effective pricing reduction pursuant to such Repricing Transaction, all in accordance with Section 2.4(d) of the Credit Agreement.
5.Proposed Borrowing.  This Agreement represents and constitutes a request by the Borrower to borrow the 2019 Incremental Term Loans from the 2019 Incremental Lender as follows (the “Proposed Borrowing”): 

a.Business Day of Proposed Borrowing:  November 26, 2019 (the “2019 Incremental Term Loan Borrowing Date”)
b.Amount of Proposed Borrowing:  $190,000,000.00
c.Interest rate option: The initial interest rate contract on the 2019 Incremental Term Loans shall be subject to the same Eurodollar Rate applicable to the Initial Term Loans for the interest period commencing on October 31, 2019.
6.Termination of Commitments.  To the extent that any 2019 Incremental Commitment has not been drawn, all such 2019 Incremental Commitment shall automatically terminate at 5:00 p.m. (New York City time) on the 2019 Term Loan Increase Effective Date.
7.Credit Agreement Governs.  This Agreement constitutes an amendment to the Credit Agreement to the extent necessary to reflect the terms hereof in accordance with Section 2.15 of the Credit Agreement. Except as set forth in this Agreement, the 2019 Incremental Term Loans shall otherwise be subject in all respects to the provisions of the Credit Agreement and the other Loan Documents.  
8.Borrower Certifications.  By its execution of this Agreement, the undersigned officer of the Borrower, to the best of his or her knowledge, hereby certifies, solely in his or her capacity as an officer of the Borrower and not in his or her individual capacity, that no Default or Event of Default exists on the date hereof before or after giving effect to the 2019 Incremental Commitment and the 2019 Incremental Term Loans contemplated hereby.
9.Conditions Precedent to Effectiveness. This Agreement will become effective on the date on which each of the following conditions is satisfied:
a.The Agent shall have received from each of the Borrower, each Guarantor (as of the 2019 Term Loan Increase Effective Date), and the 2019 Incremental Lender a counterpart of this Agreement signed on behalf of such party;
b.The Agent shall have received a legal opinion from (i) Pillsbury Winthrop Shaw Pittman LLP, counsel to the Borrower and certain of the Guarantors, and (ii) local counsel with respect to each of the Guarantors as to which Pillsbury Winthrop Shaw Pittman LLP is unable to opine, in each case in a form and in substance reasonably satisfactory to the Agent;
c.The Loan Parties shall have paid (or the Agent shall have received evidence reasonably acceptable to it that the Borrower has paid (pursuant to netting or other reduction arrangements reasonably satisfactory to the Agent)), in Dollars, in immediately available funds, (i) to the Joint Lead Arrangers, the fees in the amounts previously agreed in writing to be received on the 2019 Term Loan Increase Effective Date; and (ii) to the Joint Lead Arrangers and the Agent all reasonable fees costs and expenses (including, without limitation the reasonable fees, costs and disbursements of (x) Shearman & Sterling LLP, counsel for the 2019 Incremental Lender and the Agent, and (y) Bennett Jones LLP, Canadian counsel for the 2019 Incremental Lender and the Agent) of the Joint Lead Arrangers and the Agent for which invoices have been presented at least one (1) Business Day prior to the 2019 Term Loan Increase Effective Date;

d.The Agent shall have received at least one Business Day prior to the 2019 Term Loan Increase Effective Date, all documentation and other information required by bank regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including the PATRIOT Act and the Beneficial Ownership Regulation, that has been requested at least three Business Days prior to the 2019 Term Loan Increase Effective Date;
e.The Agent (or its counsel) shall have received a certificate of the Borrower, dated as of the 2019 Term Loan Increase Effective Date, substantially in the form of the certificate previously delivered to the Agent on the Closing Date, pursuant to Sections 3.1(d), (e), (f) and (g) to the Credit Agreement, and with the applicable attachments thereto as described in such Sections;
f.The representations and warranties set forth in Section 4 of the Credit Agreement and in each other Loan Document shall be true, correct and complete in all material respects on and as of the 2019 Term Loan Increase Effective Date and with the same effect as though made on and as of such date (including with respect to this Agreement being a “Loan Document”, and the Credit Agreement as amended hereby); provided, that to the extent such representations and warranties expressly relate to an earlier date, such representations and warranties shall be true, correct and complete in all material respects as of such earlier date; provided, further, that any representation and warranty that is qualified as to “materiality”, “Material Adverse Effect” or similar language shall be true, correct and complete in all respects on and as of the 2019 Term Loan Increase Effective Date or on such earlier date, as the case may be;
g.The certifications set forth in Section 8 above are true and correct; and
h.The Agent (or its counsel) shall have received a certificate of the Borrower, dated as of the 2019 Term Loan Increase Effective Date, certifying that at the time of such borrowing of 2019 Incremental Term Loans and after giving effect thereto, the Borrower shall be in compliance with the Available Increase Amount, which certificate shall be in reasonable detail and shall provide the calculations and basis therefor.
10.Tax Forms.  For the 2019 Incremental Lender, delivered herewith to the Agent are such forms, certificates or other evidence with respect to United States federal income tax withholding matters as the 2019 Incremental Lender may be required to deliver to the Agent pursuant to Section 16 of the Credit Agreement.
11.Recordation of the 2019 Incremental Term Loans.  Upon execution and delivery hereof, the Agent will record the 2019 Incremental Term Loans made by the 2019 Incremental Lender in the Register.

12.Amendment, Modification, Waiver and Ratification.  This Agreement may not be amended, modified or waived except by an instrument or instruments in writing signed and delivered on behalf of each of the parties hereto. Each of the Loan Parties hereby (i) ratifies and reaffirms all of its payment and performance obligations, contingent or otherwise, under each of the Loan Documents to which it is a party in accordance with the terms thereof, (ii) ratifies and reaffirms each grant of a lien on, or security interest in, its property made pursuant to the Loan Documents (including, without limitation, the grant of security made by such Loan Party pursuant to each Security Agreement to which it is a party) in accordance with the terms thereof and confirms that such liens and security interests continue to secure the Obligations, including under the Loan Documents, including, without limitation, all Obligations resulting from or incurred pursuant to the 2019 Incremental Commitment made pursuant hereto, in each case subject to the terms thereof, and (iii) in the case of each Guarantor, ratifies and reaffirms its guaranty of the Obligations pursuant to its respective Guaranty in accordance with the terms thereof.
13.Entire Agreement.  This Agreement, the Credit Agreement and the other Loan Documents constitute the entire agreement among the parties with respect to the subject matter hereof and thereof and supersede all other prior agreements and understandings, both written and verbal, among the parties or any of them with respect to the subject matter hereof.
14.GOVERNING LAW.  THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND SHALL BE INTERPRETED, CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 
15.Severability.  Any term or provision of this Agreement which is invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Agreement or affecting the validity or enforceability of any of the terms or provisions of this Agreement in any other jurisdiction.  If any provision of this Agreement is so broad as to be unenforceable, the provision shall be interpreted to be only so broad as would be enforceable.
16.Counterparts.  This Agreement may be executed in counterparts (including by facsimile or other electronic transmission), each of which shall be deemed to be an original, but all of which shall constitute one and the same agreement. 
17.Loan Document. This Agreement is a Loan Document.

[Signature Pages Follow]

IN WITNESS WHEREOF, each of the undersigned has caused its duly authorized officer to execute and deliver this First Incremental Assumption Agreement as of the date first set forth above.
CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, as 2019 Incremental Lender

By:         /s/ Judith E. Smith                                    
             Name: Judith E. Smith
             Title: Authorized Signatory

By:         Nicolas Thierry                                        
             Name: Nicolas Thierry
             Title: Authorized Signatory

UPLAND SOFTWARE, INC.,
as the Borrower
By:         /s/ Michael D. Hill                                     
             Name: Michael D. Hill
             Title:  Chief Financial Officer 

GUARANTORS    UPLAND SOFTWARE I, INC.,
a Delaware corporation 
UPLAND SOFTWARE IV, LLC, 
a Nebraska limited liability company 
UPLAND SOFTWARE V, INC., 
a Delaware corporation 
UPLAND SOFTWARE VI, LLC, 
a New Jersey limited liability company 
UPLAND SOFTWARE VII, LLC, 
a Delaware limited liability company 
UPLAND IX, LLC, 
a Delaware limited liability company 
ULTRIVA, LLC, 
a California limited liability company 
ADVANCED PROCESSING & IMAGING, INC., 
a Florida corporation 
OMTOOL, LTD., 
a Delaware corporation 
RIGHTANSWERS, INC., 
a Delaware corporation 
WATERFALL INTERNATIONAL INC., 
a Delaware corporation 
QVIDIAN CORPORATION, 
a Delaware corporation 
REFERENCES-ONLINE, INC., 
a Colorado corporation 
UPLAND SOFTWARE INC./LOGICIELS UPLAND INC., 
a Canadian federal corporation
ADESTRA INC.,
a Delaware corporation
POSTUP HOLDINGS, LLC, 
a Texas limited liability company 
POSTUP DIGITAL, LLC, 
a Texas limited liability company
DAILY INCHES, INC., 
a Delaware corporation
CIMPL USA INC., 
a Delaware corporation

By: /s/ Michael D. Hill___________________
Name: Michael D. Hill 
Title: Chief Financial Officer

POWERSTEERING SOFTWARE LIMITED,
a company organized and existing under the laws of England
RAPIDE COMMUNICATION LTD.,
a private company limited by shares organized and existing under the laws of England
RANT & RAVE LIMITED,
a private company limited by shares organized and existing under the laws of England and Wales

By: /s/ John T. McDonald______________________ 
Name: John T. McDonald 
Title: Director

Consented to by:

CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, as the Agent

By:         /s/ Judith E. Smith                                    
             Name: Judith E. Smith
             Title: Authorized Signatory

By:         Nicolas Thierry                                        
             Name: Nicolas Thierry
             Title: Authorized Signatory

SCHEDULE A TO INCREMENTAL ASSUMPTION AGREEMENT

									
	Name of 2019 Incremental Lender	Type of Commitment	Commitment Amount
	CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH	2019 Incremental Commitment	$190,000,000

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}]]